Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 61: What is true about Japanese encephalitis?

A. Transmitted by Culex mosquito
B. Caused by Group A arbovirus (Correct Answer)
C. Pig is an amplifier host
D. Man is an incidental host

Explanation: Japanese Encephalitis (JE) is a major public health concern in Southeast Asia and a high-yield topic for NEET-PG. **Explanation of the Correct Answer:** * **Option B (Caused by Group A arbovirus):** This is the **incorrect** statement among the options, making it the "correct" choice for this specific question format (assuming the question asks for the *false* statement). Japanese Encephalitis virus belongs to the **Flaviviridae** family, which are classified as **Group B Arboviruses**. Group A arboviruses (Alphaviruses) include viruses like Chikungunya and Eastern Equine Encephalitis. **Analysis of Other Options (True Statements):** * **Option A (Transmitted by Culex mosquito):** This is **true**. The primary vector is *Culex tritaeniorhynchus*, which breeds in stagnant water like rice fields. * **Option C (Pig is an amplifier host):** This is **true**. Pigs develop high-titer viremia without showing clinical signs, allowing mosquitoes to pick up the virus and spread it. They are essential for the maintenance of the transmission cycle. * **Option D (Man is an incidental host):** This is **true**. Humans are "dead-end" hosts because the level of viremia in humans is insufficient to infect a biting mosquito. **High-Yield Clinical Pearls for NEET-PG:** * **Reservoir Host:** Ardeid birds (herons, egrets). * **Amplifier Host:** Pigs (also known as "Link hosts"). * **Incubation Period:** 5 to 15 days. * **Vaccination:** The **SA-14-14-2** (Live attenuated) vaccine is used under the Universal Immunization Programme (UIP) in endemic districts of India, given at 9 months and 16–24 months. * **Seasonality:** Peak incidence usually occurs during the rainy season and post-harvest period.

Question 62: Which of the following statements are true about HIV epidemiology?

A. Children are rarely affected; less than 10% of HIV-infected persons progress to AIDS; seminal secretions are more infectious than vaginal secretions; HIV cases can infect during the window period.
B. Less than 10% of HIV-infected persons progress to AIDS; Southern Africa has 72% of the total global burden; seminal secretions are more infectious than vaginal secretions; HIV cases can infect during the window period.
C. Children are rarely affected; Southern Africa has 72% of the total global burden; seminal secretions are more infectious than vaginal secretions; HIV cases can infect during the window period. (Correct Answer)
D. Children are rarely affected; less than 10% of HIV-infected persons progress to AIDS; Southern Africa has 72% of the total global burden; HIV cases can infect during the window period.

Explanation: This question tests your knowledge of the global epidemiological trends and transmission dynamics of HIV/AIDS. ### **Explanation of the Correct Answer** The correct option (C) accurately reflects several key epidemiological facts: 1. **Children are rarely affected:** In the context of total global prevalence, pediatric cases represent a small fraction compared to the adult population (though vertical transmission remains a priority). 2. **Regional Burden:** Sub-Saharan Africa (specifically Southern and Eastern Africa) remains the epicenter, accounting for approximately **70–72%** of the global HIV burden. 3. **Infectivity of Secretions:** Seminal secretions contain a higher concentration of the virus compared to vaginal secretions, making male-to-female transmission biologically more efficient than female-to-male. 4. **Window Period:** This is the time between infection and the appearance of detectable antibodies. Individuals are **highly infectious** during this period due to high viral loads in the blood and secretions, despite testing negative on standard ELISA antibody tests. ### **Analysis of Incorrect Options** * **The "10% Progression" Fallacy:** Options A, B, and D suggest that less than 10% of HIV-infected persons progress to AIDS. This is **incorrect**. Without Antiretroviral Therapy (ART), the vast majority (over 90%) of HIV-infected individuals eventually progress to AIDS. Only a tiny fraction, known as "Long-term Non-progressors," avoid this progression. ### **High-Yield NEET-PG Pearls** * **Most Common Route:** Globally and in India, the most common route of transmission is **Heterosexual**. * **Best Screening Test:** ELISA (High sensitivity). * **Best Confirmatory Test:** Western Blot (High specificity). Note: Current WHO guidelines prioritize rapid diagnostic kits and viral load for management. * **Window Period Duration:** Usually 2–12 weeks (average 3 weeks) with modern 4th generation assays (p24 antigen + antibody). * **Rule of Halves:** HIV is often cited in public health as a disease where many are unaware of their status, highlighting the importance of the "95-95-95" targets by UNAIDS.

Question 63: Mass chemoprophylaxis is indicated for which of the following conditions?

A. Plague
B. Filaria (Correct Answer)
C. Cholera
D. Measles

Explanation: **Explanation:** **Mass Chemoprophylaxis** refers to the administration of drugs to an entire population (regardless of infection status) in a defined geographical area to interrupt disease transmission. **Why Filaria is Correct:** Lymphatic Filariasis is the classic example where **Mass Drug Administration (MDA)** is the cornerstone of the National Vector Borne Disease Control Programme (NVBDCP). In endemic districts, a single annual dose of **DEC (Diethylcarbamazine) + Albendazole** (or the triple-drug regimen **IDA**: Ivermectin + DEC + Albendazole) is administered to the entire eligible population. The goal is to reduce the microfilarial load in the community to sub-periodic levels, thereby preventing transmission by mosquitoes. **Why Other Options are Incorrect:** * **Plague:** Chemoprophylaxis (Tetracycline or Doxycycline) is indicated only for **contacts** (selective/ring prophylaxis) and high-risk health workers, not the entire mass population. * **Cholera:** Mass chemoprophylaxis is **never recommended** by the WHO because it promotes drug resistance, gives a false sense of security, and diverts resources from sanitation and rehydration. It is only considered for household contacts. * **Measles:** There is no chemoprophylaxis for measles. Prevention is achieved through **active immunization** (vaccine) or post-exposure prophylaxis using Vitamin A and Immunoglobulins in specific cases. **High-Yield Clinical Pearls for NEET-PG:** * **Mass Chemoprophylaxis** is also indicated for **Trachoma** (Azithromycin) and **Onchocerciasis** (Ivermectin). * **Selective Chemoprophylaxis** (for contacts/high-risk groups) is used in Meningococcal meningitis, H. influenzae, and Pertussis. * **MDA for Filariasis** excludes children <2 years, pregnant women, and severely ill individuals.

Question 64: Which of the following is NOT a live attenuated vaccine?

A. Oral polio vaccine (Correct Answer)
B. Yellow fever vaccine
C. Measles vaccine
D. Influenza vaccine

Explanation: **Explanation:** The question asks to identify which option is **NOT** a live attenuated vaccine. However, there is a technical discrepancy in the provided key: **Oral Polio Vaccine (Sabin), Yellow Fever, and Measles are all classic examples of live attenuated vaccines.** The correct answer to "Which is NOT a live vaccine" among these options is **D. Influenza vaccine**, specifically the injectable form (IIV), which is inactivated. **1. Why Option D (Influenza) is the most appropriate answer:** While a Live Attenuated Influenza Vaccine (LAIV) exists as a nasal spray, the standard influenza vaccine administered globally is the **Inactivated Influenza Vaccine (IIV)**. In the context of standard MCQ patterns, if a vaccine has both live and killed versions, and the other options are exclusively live, the one with a killed version is the intended answer. **2. Analysis of Incorrect Options (Live Vaccines):** * **A. Oral Polio Vaccine (Sabin):** A live attenuated vaccine. It induces both systemic (IgG) and local intestinal immunity (IgA). * **B. Yellow Fever Vaccine:** A live attenuated vaccine (17D strain). It is one of the most effective vaccines available. * **C. Measles Vaccine:** A live attenuated vaccine (Edmonston-Zagreb strain in India). It is highly heat-sensitive. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Live Vaccines:** "**B**oy **R**omeo **G**ive **M**y **L**ove **T**o **P**ollywood **S**tar" (**B**CG, **R**otavirus, **G**ermany Measles/Rubella, **M**easles/Mumps, **L**ive Influenza, **T**yphoid (Ty21a), **P**olio (Sabin), **S**mallpox/Yellow Fever). * **Contraindications:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** states (except HIV patients before clinical AIDS develops). * **Storage:** Most live vaccines are freeze-dried (lyophilized) and must be stored in the freezer compartment (except OPV, which is the most heat-sensitive).

Question 65: Under the Revised National Tuberculosis Control Programme (RNTCP), for diagnosis of Multidrug-Resistant Tuberculosis (MDR TB), which drugs are currently used for drug sensitivity testing?

A. Rifampicin
B. Rifampicin and Isoniazid
C. Rifampicin, Isoniazid, and Ethambutol (Correct Answer)
D. Rifampicin, Isoniazid, and Pyrazinamide

Explanation: ### Explanation **1. Understanding the Correct Answer (Option C)** Under the National Tuberculosis Elimination Programme (NTEP, formerly RNTCP), the diagnosis of **Multidrug-Resistant TB (MDR-TB)** is microbiologically defined as resistance to at least **Rifampicin and Isoniazid**. However, for effective treatment planning and to prevent further resistance, the standard Drug Susceptibility Testing (DST) panel for first-line drugs includes **Rifampicin, Isoniazid, and Ethambutol**. While Pyrazinamide is a core first-line drug, its DST is technically difficult and often unreliable due to the acidic pH required for the assay; therefore, Ethambutol is prioritized in the standard diagnostic DST panel to determine the baseline resistance profile before initiating a Shorter or Longer MDR-TB regimen. **2. Analysis of Incorrect Options** * **Option A:** Testing for Rifampicin alone defines **Rifampicin-Resistant TB (RR-TB)**. While RR-TB is treated as MDR-TB, the complete MDR diagnosis requires testing for Isoniazid as well. * **Option B:** While MDR-TB is defined by resistance to these two drugs, the diagnostic protocol includes Ethambutol to assess the full susceptibility profile for regimen design. * **Option D:** Pyrazinamide is excluded from routine DST because the *in vitro* testing is inconsistent and does not always correlate with *in vivo* clinical outcomes. **3. High-Yield Clinical Pearls for NEET-PG** * **MDR-TB Definition:** Resistance to *at least* Isoniazid (H) and Rifampicin (R). * **XDR-TB (New WHO Definition):** MDR/RR-TB plus resistance to any **Fluoroquinolone** AND at least one additional Group A drug (**Bedaquiline or Linezolid**). * **Universal DST (UDST):** The current policy aims to offer DST for at least Rifampicin to *all* diagnosed TB patients at the time of diagnosis. * **Diagnostic Tool of Choice:** **CBNAAT (GeneXpert)** is the initial tool for Rifampicin resistance, while **Line Probe Assay (LPA)** is used for detecting H and R resistance (First-line LPA) and Second-line drug resistance.

Question 66: What is the primary purpose of an interventional study?

A. Hypothesis Formulation
B. Hypothesis Testing
C. Hypothesis Confirmation (Correct Answer)
D. Hypothesis Manipulation

Explanation: **Explanation:** In epidemiology, the hierarchy of study designs is based on their strength in establishing causality. The primary purpose of an **interventional study** (also known as an Experimental Study or Randomized Controlled Trial) is **Hypothesis Confirmation**. 1. **Why Hypothesis Confirmation is correct:** While analytical studies (like Case-Control or Cohort) test associations to see if a relationship exists, they are prone to bias and confounding. Interventional studies involve the active manipulation of the exposure (the "intervention") under controlled conditions. This provides the highest level of evidence to confirm a cause-and-effect relationship, effectively "confirming" the hypothesis generated and tested in earlier stages. 2. **Why other options are incorrect:** * **Hypothesis Formulation (A):** This is the domain of **Descriptive Epidemiology** (Case reports, Case series, and Ecological studies). They observe patterns of disease to suggest possible causes. * **Hypothesis Testing (B):** This is the primary goal of **Analytical Epidemiology** (Case-Control and Cohort studies). These studies use statistical methods to determine if there is a significant association between an exposure and an outcome. * **Hypothesis Manipulation (D):** This is a distractor term. In interventional studies, we manipulate the *variables* or *exposure*, not the hypothesis itself. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** The Randomized Controlled Trial (RCT) is the gold standard for evaluating the efficacy of a new drug or intervention. * **Sequence of Study:** Descriptive (Formulation) → Analytical (Testing) → Experimental (Confirmation). * **Key Feature:** The distinguishing feature of an interventional study is the **investigator's control** over the assignment of participants to groups (usually via Randomization). * **Ethical Constraint:** Interventional studies can only be performed when there is "equipoise" (genuine uncertainty about which treatment is better).

Question 67: ELISA is performed on a population with low prevalence. What would be the result of performing double screening ELISA tests?

A. Increased sensitivity and positive predictive value
B. Increased sensitivity and negative predictive value
C. Increased specificity and positive predictive value (Correct Answer)
D. Increased specificity and negative predictive value

Explanation: ### Explanation This question tests the understanding of **Sequential (Serial) Screening** and its impact on diagnostic parameters. **1. Why Option C is Correct:** When we perform "double screening" (sequential testing), we only consider a person "positive" if they test positive on **both** tests. * **Increased Specificity:** By requiring two positive results, we significantly reduce the number of false positives. This makes the testing process more "strict," thereby increasing the overall specificity. * **Increased Positive Predictive Value (PPV):** PPV is the probability that a person with a positive test actually has the disease. Since sequential testing filters out false positives, the "purity" of the positive pool increases, leading to a higher PPV. This is particularly useful in **low-prevalence** settings (like ELISA for HIV screening) to avoid unnecessary psychological trauma or treatment for false positives. **2. Why Other Options are Wrong:** * **Sensitivity (Options A & B):** In sequential testing, sensitivity actually **decreases**. This is because a person must pass two hurdles to be called positive; if they test negative on either test, they are labeled negative, increasing the chance of false negatives. * **Negative Predictive Value (Options B & D):** While NPV is generally high in low-prevalence settings, sequential testing primarily aims to improve the "rule-in" power (PPV/Specificity) rather than the "rule-out" power (NPV). **3. High-Yield Clinical Pearls for NEET-PG:** * **Sequential Testing:** Increases **Specificity** and **PPV**. (Used for HIV: ELISA followed by Western Blot). * **Parallel Testing:** (Running two tests simultaneously) Increases **Sensitivity** and **NPV**. (Used when you don't want to miss a single case, e.g., screening blood donors). * **Prevalence Relationship:** * Prevalence $\uparrow$ = PPV $\uparrow$ * Prevalence $\downarrow$ = NPV $\uparrow$ * **Screening Goal:** In low-prevalence populations, the biggest challenge is the high number of false positives; hence, sequential testing is the strategy of choice to boost PPV.

Question 68: What is the term for a disease introduced to a country for the first time?

A. Exotic disease (Correct Answer)
B. Epidemic
C. Endemic
D. Hyperendemic

Explanation: ### Explanation **Correct Answer: A. Exotic disease** **Why it is correct:** An **exotic disease** is defined as a disease which is imported into a country in which it does not otherwise occur. The term is derived from the fact that the pathogen is "foreign" or "alien" to the local geographical area. A classic example in the Indian context is **Yellow Fever**; although the vector (*Aedes aegypti*) is present, the disease itself is not endemic, making any introduction "exotic." **Why the other options are incorrect:** * **B. Epidemic:** This refers to the occurrence of cases of an illness in a community or region clearly in **excess of normal expectancy**. It relates to the *frequency* of the disease, not its origin. * **C. Endemic:** This refers to the **constant presence** of a disease or infectious agent within a given geographic area or population group without external importation (e.g., Typhoid in India). * **D. Hyperendemic:** This describes a situation where a disease is constantly present at a **high incidence and/or prevalence** rate and affects all age groups equally (e.g., Malaria in certain African regions). **NEET-PG High-Yield Pearls:** * **Sporadic:** Scattered cases occurring irregularly and haphazardly (e.g., Tetanus). * **Pandemic:** An epidemic that spreads across several countries or continents, usually affecting a large number of people (e.g., COVID-19, Influenza). * **Enzootic/Epizootic:** These are the animal equivalents of endemic and epidemic, respectively. * **Epornithic:** An epidemic occurring in a bird population. * **Zoonosis:** An infection transmissible under natural conditions from vertebrate animals to man (e.g., Rabies, Brucellosis).

Question 69: What is the term for a disease imported into a country that was not otherwise present?

A. Epornitic disease
B. Zoonotic disease
C. Exotic disease (Correct Answer)
D. Epizootic disease

Explanation: ### Explanation **Correct Answer: C. Exotic disease** **1. Why it is correct:** In epidemiology, an **exotic disease** is defined as a disease that is imported into a country or geographic region where it does not otherwise occur. These diseases are introduced from the outside, often through international travel, trade, or migration. A classic example in the Indian context is **Yellow Fever**; while the vector (*Aedes aegypti*) is present in India, the disease itself is not endemic and is considered exotic. **2. Analysis of Incorrect Options:** * **A. Epornitic disease:** This refers to an epidemic or outbreak of disease occurring within a **bird population**. It is the avian equivalent of an "epizootic." * **B. Zoonotic disease:** These are infections that are naturally transmissible from **vertebrate animals to humans** (e.g., Rabies, Brucellosis, Plague). The term describes the source of infection, not its geographic status. * **C. Epizootic disease:** This refers to an outbreak of disease that rapidly affects a large number of **animals** in a specific area at the same time (e.g., Anthrax or Foot and Mouth Disease). It is the animal equivalent of an "epidemic" in humans. **3. NEET-PG High-Yield Pearls:** * **Enzootic:** A disease that is constantly present in an animal population (equivalent to "endemic" in humans). * **Epornithic:** An outbreak in birds. * **Yellow Fever Prevention:** To prevent the introduction of this exotic disease into India, strict international health regulations (IHR) require travelers from endemic zones to possess a valid **Yellow Fever Vaccination Certificate** (valid for life, starting 10 days after vaccination). * **Zoonoses Classification:** * *Orthozoonoses:* Cycle maintained in one vertebrate (e.g., Rabies). * *Cyclozoonoses:* Requires more than one vertebrate host (e.g., Echinococcosis). * *Metazoonoses:* Requires an invertebrate vector (e.g., Plague).

Question 70: In a population, the incidence of an autosomal recessive disease is 1/250,000. What is the carrier frequency in this population?

A. 1/250 (Correct Answer)
B. 1/500
C. 1/1000
D. 1/5000

Explanation: ### Explanation This question is based on the **Hardy-Weinberg Principle**, which is a high-yield topic in Epidemiology and Genetics. The principle uses the equation: **$p^2 + 2pq + q^2 = 1$**, where: * **$q^2$** = Frequency of the disease (homozygous recessive individuals) * **$2pq$** = Frequency of carriers (heterozygous individuals) * **$p$** = Frequency of the normal allele **1. Why Option A is Correct:** * **Step 1:** Find $q$. The incidence ($q^2$) is given as $1/250,000$. $q = \sqrt{1/250,000} = 1/500$. * **Step 2:** Find $p$. Since $p + q = 1$, and $q$ is very small, $p$ is approximately $1$. * **Step 3:** Calculate carrier frequency ($2pq$). $2 \times 1 \times (1/500) = 2/500 = \mathbf{1/250}$. **2. Why Other Options are Incorrect:** * **Option B (1/500):** This represents $q$ (the gene frequency of the abnormal allele), not the carrier frequency ($2pq$). * **Option C (1/1000):** This is a calculation error, likely from forgetting to multiply by 2 in the $2pq$ formula. * **Option D (1/5000):** This value is mathematically unrelated to the square root of the given incidence. **3. Clinical Pearls for NEET-PG:** * **Shortcut:** For rare autosomal recessive diseases, if the incidence is $1/X$, the carrier frequency is approximately $2/\sqrt{X}$. * **Hardy-Weinberg Equilibrium** assumes a large population, random mating, and no selection, mutation, or migration. * **Application:** This formula is used in genetic counseling to estimate the risk of a couple having an affected child when one or both are asymptomatic carriers.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free